Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Akasaka, Harue ^a   Sato, Fuyuki ^a   Morohashi, Satoko ^a   Wu, Yunyan ^a,b   Liu, Yang ^a,b   Kondo, Jun ^a   Odagiri, Hiroki ^a   Hakamada, Kenichi ^a   Kijima, Hiroshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CLAUDIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALL INTERFERING RNA; TAMOXIFEN; UVOMORULIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CADHERIN; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL MEMBRANE; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; CELL NUCLEUS; DOSE RESPONSE; FEMALE; GENE EXPRESSION PROFILING; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; RNA, SMALL INTERFERING; TAMOXIFEN;

EID: 77957736262     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-548     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
2. Sjöström J, Bergh J. How apoptosis is regulated, and what goes wrong in cancer. BMJ 2001, 322:1538-1539. Review, 10.1136/bmj.322.7301.1538, 1120577, 11420280.
3. Chang J, Powles TJ, Allred DC, Ashley SE, Makris A, Gregory RK, Osborne CK, Dowsett M. Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients. Clin Cancer Res 2000, 6:616-621.
4. Sutherland RL, Green MD, Hall RE, Reddel RR, Taylor IW. Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur J Cancer Clin Oncol 1983, 19:615-621. 10.1016/0277-5379(83)90177-3, 6683633.
5. Perry RR, Kang Y, Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol 1995, 2:238-245. 10.1007/BF02307030, 7641021.
6. Martin G, Melito G, Rivera E, Levin E, Davio C, Cricco G, Andrade N, Caro R, Bergoc R. Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors. Cancer Lett 1996, 100:227-234. 10.1016/0304-3835(95)04091-9, 8620446.
7. Lagadec C, Adriaenssens E, Toillon RA, Chopin V, Romon R, Van Coppenolle F, Hondermarck H, Le Bourhis X. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells. Oncogene 2008, 27:1472-1477. 10.1038/sj.onc.1210749, 17767197.
8. Kang Y, Cortina R, Perry RR. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J Natl Cancer Inst 1996, 88:224-226. 10.1093/jnci/88.5.224, 8613997.
9. Duh JL, Yu R, Jiao JJ, Matwyshyn GA, Li W, Tan TH, Kong AN. Activation of signal transduction kinases by tamoxifen. Pharm Res 1997, 14:186-189. 10.1023/A:1012048626963, 9090707.
10. Mandlekar S, Yu R, Tan TH, Kong AN. Activation of caspase-3 and c-Jun NH2-terminal kinase -1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 2000, 60:5995-6000.
11. Ichikawa A, Ando J, Suda K. G1 arrest and expression of cyclin-dependent kinase inhibitors in tamoxifen-treated MCF-7 human breast cancer cells. Hum Cell 2008, 21:28-37. 10.1111/j.1749-0774.2008.00048.x, 18397472.
12. Cereijido M, Contreras RG, Shoshani L, Flores-Benitez D, Larre I. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biophys Acta 2008, 1778:770-793. Review, 10.1016/j.bbamem.2007.09.001, 18028872.
13. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005, 115:1765-1776. 10.1172/JCI24543, 1150288, 15965503.
14. Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, Komori T, Ito A, Yokozaki H. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006, 37:569-577. 10.1016/j.humpath.2005.12.018, 16647955.
15. Oliveira SS, Morgado-Díaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 2007, 64:17-28. 10.1007/s00018-006-6314-1, 17115119.
16. Tokés AM, Kulka J, Paku S, Szik A, Páska C, Novák PK, Szilák L, Kiss A, Bögi K, Schaff Z. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 2005, 7:R296-R305. 10.1186/bcr983, 1064136, 15743508.
17. Morohashi S, Kusumi T, Sato F, Odagiri H, Chiba H, Yoshihara S, Hakamada K, Sasaki M, Kijima H. Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int J Mol Med 2007, 20:139-143.
18. Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998, 143:391-401. 10.1083/jcb.143.2.391, 2132845, 9786950.
19. Tsukita S, Furuse M. Overcoming barriers in the study of tight junction functions: from occludin to claudin. Genes Cells 1998, 3:569-573. Review, 10.1046/j.1365-2443.1998.00212.x, 9813107.
20. Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PR. Apoptotic mechanisms in T47 D and MCF-7 human breast cancer cells. Br J Cancer 2002, 87:909-917. 10.1038/sj.bjc.6600541, 2376174, 12373608.
21. Sandhya T, Mishra KP. Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to triphala and its modification by antioxidants. Cancer letter 2006, 238:304-313.
22. Osanai M, Murata M, Chiba H, Kojima T, Sawada N. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci 2007, 98:1557-1562. 10.1111/j.1349-7006.2007.00569.x, 17645772.
23. Lee JW, Hsiao WT, Chen HY, Hsu LP, Chen PR, Lin MD, Chiu SJ, Shih WL, Hsu YC. Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells. Int J Cancer 2010, 126:1353-1366.
24. Kondo J, Sato F, Kusumi T, Liu Y, Motonari O, Sato T, Kijima H. Claudin-1 expression is induced by tumor necrosis factor-alpha in human pancreatic cancer cells. Int J Mol Med 2008, 22:645-649.
25. Yang SZ, Kohno N, Kondo K, Yokoyama A, Hamada H, Hiwada K, Miyake M. Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Int J Oncol 1999, 15:1109-1115.
26. Peluso JJ, Pappalardo A, Hess SA. Effect of disrupting cell contact on the nuclear accumulation of beta-catenin and subsequent apoptosis of rat ovarian surface epithelial cells in vitro. Endocrine 2000, 12:295-302. 10.1385/ENDO:12:3:295, 10963051.
27. Wang D, Xiang DB, He YJ, Li ZP, Wu XH, Mou JH, Xiao HL, Zhang QH. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of colorectal cancer cells in vitro. World J Gastroenterol 2005, 11:4008-4012.
28. He YJ, Liu BH, Xiang DB, Qiao ZY, Fu T, He YH. Inhibitory effect of caffeic acid phenethyl ester on the growth of SW480 colorectal tumor cells involves beta-catenin associated signaling pathway down-regulation. World J Gastroenterol 2006, 12:4981-4985.
29. Van Veldhuizen PJ, Ray G, Banerjee S, Dhar G, Kambhampati S, Dhar A, Banerjee SK. 2-Methoxyestradiol modulates beta-catenin in prostate cancer cells: a possible mediator of 2-methoxyestradiol-induced inhibition of cell growth. Int J Cancer 2008, 122:567-571. 10.1002/ijc.23117, 17935127.